Even if you're careful, drugs can end up in water

PORTLAND, Maine — The federal government advises throwing most unused or expired medications into the trash instead of down the drain, but they can end up in the water anyway, a study from Maine suggests.

Tiny amounts of discarded drugs have been found in water at three landfills in the state, confirming suspicions that pharmaceuticals thrown into household trash are ending up in water that drains through waste, according to a survey by the state's environmental agency that's one of only a handful to have looked at the presence of drugs in landfills.

That landfill water — known as leachate — eventually ends up in rivers. Most of Maine doesn't draw its drinking water from rivers where the leachate ends up, but in other states that do, water supplies that come from rivers could potentially be contaminated.

The results of the survey are being made known as lawmakers in Maine consider a bill, among the first of its kind in the nation, that would require drug manufacturers to develop and pay for a program to collect unused prescription and over-the-counter drugs from residents and dispose of them.

Scientists and environmentalists have long known of the common presence of minute concentrations of pharmaceuticals in drinking water, either through human excretion flushed into sewers or leftover medicine thrown down the drain. Research shows that pharmaceuticals sometimes harm fish and other aquatic species, and that human cells can fail to grow normally in the laboratory when exposed to trace concentrations of certain drugs.

The Maine Department of Environmental Protection found tiny amounts — measured in parts per trillion — of medications ranging from antidepressants and birth control pills to blood pressure and cholesterol prescriptions. The most prevalent drugs were over-the-counter pain relievers, including ibuprofen and acetaminophen.

"People need a way to properly dispose of their drugs, and they're not getting it right now," said Mark Hyland, director of the state Department of Environmental Quality's Bureau of Remediation and Waste Management.

The bill is one of many "take-back" programs under consideration in more than half a dozen states and would be the first of its kind if enacted; it has won committee support and awaits further action.

The bill is opposed by the Pharmaceutical Research and Manufacturers of America, a Washington-based organization that represents pharmaceutical and biotechnology companies and has partnered with other groups to pay for advertising against the proposal.